{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:33:53Z","timestamp":1792186433477,"version":"4.4.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2020.561502","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T04:21:07Z","timestamp":1604463667000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Hantavirus Infection Is Inhibited by Griffithsin in Cell Culture"],"prefix":"10.3389","volume":"10","author":[{"given":"Punya","family":"Shrivastava-Ranjan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payel","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart T.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry R.","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina F.","family":"Spiropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3201\/eid2604.190799","article-title":"Person-to-person transmission of andes virus in hantavirus pulmonary syndrome, argentina, 2014","volume":"26","author":"Alonso","year":"2020","journal-title":"Emerg. Infect. Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2016.05.014","article-title":"Effect of Vandetanib on Andes virus survival in the hamster model of Hantavirus pulmonary syndrome","volume":"132","author":"Bird","year":"2016","journal-title":"Antiviral Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/v11070610","article-title":"Progress on the prevention and treatment of hantavirus disease","volume":"11","author":"Brocato","year":"2019","journal-title":"Viruses"},{"key":"B4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/135965359900400404","article-title":"Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience","volume":"4","author":"Chapman","year":"1999","journal-title":"Ribavirin study group. Antivir. Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1600-0684.2007.00242.x","article-title":"Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide","volume":"36","author":"Emau","year":"2007","journal-title":"J. Med. Primatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/rcm.1844","article-title":"Global and site-specific detection of human integrin alpha 5 beta 1 glycosylation using tandem mass spectrometry and the StrOligo algorithm","volume":"19","author":"Ethier","year":"2005","journal-title":"Rapid Commun. Mass Spectrom"},{"key":"B7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1128\/JVI.00481-09","article-title":"Interactions and oligomerization of hantavirus glycoproteins","volume":"84","author":"Hepojoki","year":"2010","journal-title":"J. Virol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1006\/viro.2001.1133","article-title":"A lethal disease model for hantavirus pulmonary syndrome","volume":"289","author":"Hooper","year":"2001","journal-title":"Virology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.1128\/JVI.00057-10","article-title":"Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses","volume":"84","author":"Huiskonen","year":"2010","journal-title":"J. Virol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00705-012-1489-2","article-title":"Griffithsin inhibits Japanese encephalitis virus infection in vitro in vitro and in vivoin vivo","volume":"158","author":"Ishag","year":"2013","journal-title":"Arch. Virol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.virusres.2016.01.016","article-title":"Griffithsin binds to the glycosylated proteins (E and prM) of Japanese encephalitis virus and inhibit its infection","volume":"215","author":"Ishag","year":"2016","journal-title":"Virus Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1128\/CMR.00062-09","article-title":"A global perspective on hantavirus ecology, epidemiology, and disease","volume":"23","author":"Jonsson","year":"2010","journal-title":"Clin. Microbiol. Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.antiviral.2007.10.012","article-title":"Treatment of hantavirus pulmonary syndrome","volume":"78","author":"Jonsson","year":"2008","journal-title":"Antiviral Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S480","DOI":"10.1093\/infdis\/jiz630","article-title":"Griffithsin inhibits nipah virus entry and fusion and can protect Syrian golden hamsters from lethal nipah virus challenge","volume":"221","author":"Lo","year":"2020","journal-title":"J. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/v8100296","article-title":"Griffithsin: an antiviral lectin with outstanding therapeutic potential","volume":"8","author":"Lusvarghi","year":"2016","journal-title":"Viruses"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3201\/eid1112.050501","article-title":"Person-to-person transmission of Andes virus","volume":"11","author":"Martinez","year":"2005","journal-title":"Emerg. Infect. Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1128\/JVI.02415-12","article-title":"Host mTORC1 signaling regulates andes virus replication","volume":"87","author":"McNulty","year":"2013","journal-title":"J. Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1086\/425007","article-title":"Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America","volume":"39","author":"Mertz","year":"2004","journal-title":"Clin. Infect. Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"5159","DOI":"10.1128\/AAC.00633-11","article-title":"Griffithsin has antiviral activity against hepatitis C virus","volume":"55","author":"Meuleman","year":"2011","journal-title":"Antimicrob. Agents Chemother"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2016.07.011","article-title":"Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin","volume":"133","author":"Millet","year":"2016","journal-title":"Antiviral Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/bs.aivir.2019.07.002","article-title":"Hantavirus entry perspectives and recent advances","volume":"104","author":"Mittler","year":"2019","journal-title":"Adv. Virus Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.antiviral.2015.05.003","article-title":"Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses","volume":"120","author":"Mohr","year":"2013","journal-title":"Antiviral Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12977-014-0127-3","article-title":"Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus","volume":"12","author":"Moulaei","year":"2015","journal-title":"Retrovirology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1128\/JVI.02322-09","article-title":"Broad-spectrum in vitro in vitro activity and in vivoin vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae","volume":"84","author":"O'Keefe","year":"2010","journal-title":"J. Virol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1073\/pnas.0901506106","article-title":"Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component","volume":"106","author":"O'Keefe","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1128\/AAC.00886-13","article-title":"Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome","volume":"57","author":"Safronetz","year":"2013","journal-title":"Antimicrob. Agents Chemother"},{"key":"B27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3201\/eid0302.970202","article-title":"Hantaviruses: a global disease problem","volume":"3","author":"Schmaljohn","year":"1997","journal-title":"Emerg. Infect. Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jmv.10446","article-title":"Genetic characterisation of a Hantavirus isolated from a laboratory-acquired infection","volume":"71","author":"Shi","year":"2003","journal-title":"J. Med. Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e01808","DOI":"10.1128\/mBio.01808-16","article-title":"25-Hydroxycholesterol inhibition of Lassa virus infection through aberrant GP1 glycosylation","volume":"7","author":"Shrivastava-Ranjan","year":"2016","journal-title":"mBio"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e00660","DOI":"10.1128\/mBio.00660-18","article-title":"Statins suppress Ebola virus infectivity by interfering with glycoprotein processing","volume":"9","author":"Shrivastava-Ranjan","year":"2018","journal-title":"mBio"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11227","DOI":"10.1128\/JVI.01405-10","article-title":"Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin","volume":"84","author":"Shrivastava-Ranjan","year":"2010","journal-title":"J. Virol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/v11070645","article-title":"Vesicular stomatitis virus-based vaccines provide cross-protection against andes and sin nombre viruses","volume":"11","author":"Warner","year":"2019","journal-title":"Viruses"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1073\/pnas.0902239106","article-title":"Second-generation HIV microbicides: continued development of griffithsin","volume":"106","author":"Zeitlin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S A."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2020.561502\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T13:07:24Z","timestamp":1669468044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2020.561502\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":33,"alternative-id":["10.3389\/fcimb.2020.561502"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.561502","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]},"article-number":"561502"}}